Literature DB >> 1664760

The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.

J F Herrero1, P M Headley.   

Abstract

1. Flexor withdrawal reflexes to noxious mechanical pinch stimuli were recorded as single motor unit activity in alpha-chloralose anaesthetized rats, by means of tungsten bipolar electrodes inserted percutaneously into hindlimb flexor muscles. The relative spinal and supraspinal contributions to mu- and kappa-opioid agonists in inhibiting these spinal reflexes, together with possible potency changes elicited by surgical trauma, were examined by comparing their relative potencies in spinally unoperated, sham spinalized and spinalized rats. 2. The noxious stimuli, which were of comparable intensity in the three groups, elicited similar mean firing rates of the motor units in all groups. This indicates that the excitability levels in the reflex pathway were not greatly affected by either sham or actual spinalization. 3. The mu-agonists morphine and fentanyl, and the kappa-agonist U-50,488H, inhibited the reflexes in a dose-dependent manner, when administered intravenously in a log2 cumulative dose regime. 4. The surgery of sham spinalization had little effect on the potency of morphine and fentanyl, whereas it doubled the potency of U-50,488. 5. Spinalization did not affect the potency of morphine. In contrast it decreased the potency of fentanyl 2-4 fold and that of U-50,488 approximately 6 fold. 6. The effects of all agonists were antagonized by naloxone. Dose-dependence studies indicating that antagonism of U-50,488H required about 5 times the dose of naloxone that antagonized morphine. 7. The data suggest that surgical trauma to the spinal column and/or dura mater triggers supraspinal mechanisms that significantly enhance the potency of kappa- but not mu-agonists. 8. It is concluded that most of the effects of systemic morphine on spinal reflexes are mediated, under all three conditions tested, by direct effects in the spinal cord. In contrast, the inhibition of reflexes by U-50,488H is mediated at both spinal and supraspinal levels, the latter being enhanced in the presence of surgical trauma. The differences between morphine and fentanyl remain unexplained.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664760      PMCID: PMC1908269          DOI: 10.1111/j.1476-5381.1991.tb12402.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Spinal effects of four injectable anaesthetics on nociceptive reflexes in rats: a comparison of electrophysiological and behavioural measurements.

Authors:  N A Hartell; P M Headley
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions.

Authors:  Allan I Basbaum; Nicholas J E Marley; John O'Keefe; Charles H Clanton
Journal:  Pain       Date:  1977-02       Impact factor: 6.961

3.  Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.

Authors:  C G Parsons; D C West; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.

Authors:  M J Millan; A Członkowski; A Lipkowski; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

5.  Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat.

Authors:  P J Hope; S M Fleetwood-Walker; R Mitchell
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

6.  Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.

Authors:  D Paul; R J Bodnar; M A Gistrak; G W Pasternak
Journal:  Eur J Pharmacol       Date:  1989-09-22       Impact factor: 4.432

7.  Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.

Authors:  C G Parsons; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.

Authors:  R J Knox; A H Dickenson
Journal:  Brain Res       Date:  1987-07-07       Impact factor: 3.252

9.  Spinal vs. supraspinal actions of morphine on the rat tail-flick reflex.

Authors:  J G Sinclair; C D Main; G F Lo
Journal:  Pain       Date:  1988-06       Impact factor: 6.961

10.  Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

Authors:  A E Takemori; B Y Ho; J S Naeseth; P S Portoghese
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

View more
  13 in total

1.  Subeffective doses of dexketoprofen trometamol enhance the potency and duration of fentanyl antinociception.

Authors:  Gema Gaitán; Juan F Herrero
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  NCX-701 (nitroparacetamol) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up.

Authors:  E Alfonso Romero-Sandoval; Javier Mazario; David Howat; Juan F Herrero
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 3.  Kappa opioids and the modulation of pain.

Authors:  Bronwyn Kivell; Thomas E Prisinzano
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

4.  Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. I. Effects after oral administration.

Authors:  E A Romero-Sandoval; C Molina; M Alique; V Moreno-Manzano; F J Lucio; J F Herrero
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

5.  NCX 2057, a novel NO-releasing derivative of ferulic acid, suppresses inflammatory and nociceptive responses in in vitro and in vivo models.

Authors:  Daniela Ronchetti; Valentina Borghi; Gema Gaitan; Juan F Herrero; Francesco Impagnatiello
Journal:  Br J Pharmacol       Date:  2009-07-07       Impact factor: 8.739

6.  Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.

Authors:  J F Herrero; P M Headley
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.

Authors:  Gema Gaitan; F Javier Ahuir; Piero Del Soldato; Juan F Herrero
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

8.  Antinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: enhancement of antinociception by co-administration with gabapentin.

Authors:  M Mar Curros-Criado; Juan F Herrero
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

9.  Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID.

Authors:  J F Herrero; P M Headley
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

10.  kappa-Opioid receptors also increase potassium conductance.

Authors:  T J Grudt; J T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.